改良jarnagin-blumgart分期在肝门部胆管癌术中评估中的应用及临床意义.docx

浙江大学医学院 外科学(普外) 硕士研究生 杨一飞
导 师 曹利平
中文摘要
目的:
比较Bismuth—Corlette(B—C)分型,TNM分期,(J—B) 分期三种不同临床分期方法对肝门部胆管癌(hilar cholangiocarcinoma,HCCA)患者预后评估的准确性,,使之更为准确的对肝门部胆管癌患者预后进行术后评估。
方法:
回顾性分析154例肝门部胆管癌临床和病理资料,() 分型、TNM分期、(J—B)分期三种方法分别进行分期,比较可切除性及预后相关因素的分析。(J。B)分期
的预后评估模型。
结果:
根据Jarnagin—Blumgart(J—B)分期:J-B %(48/70),
II
万方数据
浙江大学硕士学位论文 中文摘要
高于J—B T2期(%,P=)。J-B T3期(%, P=)。:%,%,%,%。TNM分期:I期根治切除26例,II期根治切除30例,III期根治切除21例,Ⅳ期根治性切除2例。B。C分型(P--) 以及TNM分期(P=)在根治切除率方面差异无明显差异。%,。
结论:
J—B分期比B—c分型在预测手术的根治切除率方面更为全面,但对肝门部胆管癌手术患者的术后生存时间的评估没有优于TNM分期系统。。
关键词:肝门胆管癌;生存;;预后
III
万方数据
浙江大学硕士学位论文 英文摘要
A modified Jarnagin—Blumgart classification better predicts
survival for resectable hilar cholangiocarcinoma
School ofMedicine,Zhejiang University Department of Surgery
Candidate Yang Yifei Supervisor Liping
Abstract Objective:
To assess the respectability and prognosis of hilar cholangiocarcinoma by Bismuth— Corlette,TNM and Jarnagin— establishing a improved model urate prognosis evaluation of hila cholangiocarcinoma.
Methods:
Retrospective analysis of 1 54 cases of clinical and pathological data of hilar cholangiocarcinoma,according to Bismuth—Corlette,TNM,and Jarnagin—Blumgart, comparing surgical resection rate and Jamagin—Blumgart staging system was used to estavlish for prognosis evaluation.
Results:
The resection rate of J—B T1 was %,which was higher than J-B T2(%,P2 ).The resection rate of J—B T2 was higher than J—B T3(1 %,P=).By IV
万方数据
浙江大学硕士学位论文英文摘要
Bismuth—Corlette classification:The radical resection rate was %,%,%,
1 %.By TNM staging system:26,